Twist Bioscience Corporation (TWST) USD0.00001

Sell:$51.70Buy:$51.87$2.27 (4.57%)

NASDAQ:0.12%
Prices delayed by at least 15 minutes
Sell:$51.70
Buy:$51.87
Change:$2.27 (4.57%)
Prices delayed by at least 15 minutes
Sell:$51.70
Buy:$51.87
Change:$2.27 (4.57%)
Prices delayed by at least 15 minutes

Company Information

About this company

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. It is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. It makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.

Key people

Emily M. Leproust
Chairman of the Board, Chief Executive Officer
Patrick John Finn
President, Chief Operating Officer
Adam Laponis
Chief Financial Officer
Paula Green
Senior Vice President - Human Resources
Robert Werner
Chief Accounting Officer, Vice President
Dennis Cho
Chief Legal Officer and Corporate Secretary
Robert B. Chess
Lead Independent Director
Nelson C. Chan
Independent Director
Keith L. Crandell
Independent Director
Jan Johannessen
Independent Director
Xiaoying Mai
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US90184D1000
  • Market cap
    $3.09bn
  • Employees
    923
  • Shares in issue
    59.58m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.